ECSP961824A - Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1) - Google Patents
Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1)Info
- Publication number
- ECSP961824A ECSP961824A ECSP961824A ECSP961824A EC SP961824 A ECSP961824 A EC SP961824A EC SP961824 A ECSP961824 A EC SP961824A EC SP961824 A ECSP961824 A EC SP961824A
- Authority
- EC
- Ecuador
- Prior art keywords
- heptanoic
- methylethyl
- carbonyl
- calcium salt
- form iii
- Prior art date
Links
- 159000000007 calcium salts Chemical class 0.000 title abstract 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 title 1
- -1 METHYLETHYL Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 abstract 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una forma cristalina nueva de sal de calcio de ácido [R-(R*, R*)-2-(4-fluorofenil)-ß, 8-dihidroxi-5-(1-metiletil)-3-fenil-4-[(fenilamino)carbonil]-1H-pirrol-1-heptanoico (2:1) denominada Forma III caracterizada por la difracción de cristales finos de rayos X y/o resonancia magnética nuclear descripta, así como los métodos para la elaboración y composición farmacéutica de la misma, que es útil como agente para tratar la hiperlipidemia e hipercolesterolemia.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961824 ECSP961824A (es) | 1996-07-17 | 1996-07-17 | Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961824 ECSP961824A (es) | 1996-07-17 | 1996-07-17 | Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961824A true ECSP961824A (es) | 1997-12-09 |
Family
ID=42042554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961824 ECSP961824A (es) | 1996-07-17 | 1996-07-17 | Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1) |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961824A (es) |
-
1996
- 1996-07-17 EC ECSP961824 patent/ECSP961824A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR003459A1 (es) | Forma iii cristalina de atorvastatina y sus hidratos y composiciones farmaceuticas con la misma. | |
| MY118398A (en) | FORM 111 CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß, S- DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO) CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1). | |
| GEP20053546B (en) | Crystalline Forms of 'R-(R*,R*)!-2-(4- Fluorophenyl)-Beta, Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-'Phenylamino) Carbonyl!-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1) (Atorvastatin) | |
| KR910002794A (ko) | 〔R-(R*,R*)〕-2-(4-플루오로페닐)β,σ-디히드록시-5-1-(1-메틸에틸)-3-페닐-4〔페닐아미노)카르보닐〕-1H-피롤-1헵탄산, 그의 락톤형 및 염류 | |
| AR004122A1 (es) | Procedimiento para la preparacion de un compuesto de dihaloazolopirimidinas y un procedimiento para la preparacion de un intermediario de dicho procedimiento | |
| DK0839132T5 (da) | Fremgangsmåde til fremstilling af amorft [R-(R*,R*)]-2-(4-fluorphenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptansyrecalciumsalt (2:1) | |
| BR0113200A (pt) | Combinação terapêutica | |
| ECSP961824A (es) | Forma iii cristalina de sal de calcio de acido [r-(r*,r*)- 2-(4 fluorofenil) - b, g- dihidroxi-5-(1 metiletil) - 3- fenil - 4-[(fenilamino) carbonil]- 1h -pirrol - 1- heptanoico (2.1) | |
| AR045654A1 (es) | Formas cristalinas de acido r-(r*,r*)-2-(4- fluorofenil) - , dihidroxi - 5-(1- metiletil)- 3- fenil- 4-( fenilamino) - carbonil- 1h- pirrol-1- heptanoico | |
| DE69616358D1 (de) | Kristalline form iii des hemi calcium salzes von [r-(r*,r*)]-2-(4-fluorphenyl)-beta-delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrol-1-heptansäure (atorvastatin) | |
| ECSP961823A (es) | Acido cristalino [r- (r*, r*)]- 2- (4- fluorofenil) -b, 8 -dihidroxi- 5- (1- metiletil) - 3 - fenil- 4- [(fenilamino) carbonil]- 1h- pirrol - 1- heptanoico sal de calcio (2.1) | |
| UY27608A1 (es) | Formas cristalinas hidratadas de atorvastatina forma ii y forma iv. | |
| TH13382B (th) | ผลึกรูปแบบ lll ของเกลือแคลเซียม (2 | |
| TH32710A (th) | ผลึกรูปแบบ lll ของเกลือแคลเซียม (2 |